Physician profile
Hunter Starring
NPI 1962961102
$7,918.30
in general payments reported to CMS, 2019-2025
11 companies · $3,373 in 2025
The $3,373 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,066 · 2023: $230 · 2024: $3,249 · 2025: $3,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,909 · Food and Beverage: $1,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,908.99 |
| Food and Beverage | $1,943.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,040.32 | 2025 | Excelsius Gps, Reline |
| Highridge Medical LLC | $2,132.34 | 2024 | The Tether |
| Stryker Corporation | $1,249.27 | 2022-2025 | Gamma, Aequalis Ascend Flex, Hoffmann |
| Depuy Synthes Sales INC. | $447.72 | 2024-2025 | Viper, Conduit, Na |
| Medtronic, INC. | $383.37 | 2024 | Unid_pass, Cd Horizon Spinal System |
| Biotissue Holdings INC. | $149.21 | 2024 | |
| Zimvie INC. | $144.15 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $124.69 | 2022 | |
| Orthopediatrics Corp. | $110.46 | 2025 | |
| Alon Medical Technology | $100.20 | 2022 | |
| Biomarin Pharmaceutical INC. | $36.57 | 2023 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Starring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.